Facebook
Twitter
Telegram
Report an ErrorXBiotech Financial Ratios 2011-2024 | XBIT
Annual Financial Ratios XBiotech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-38.8 | -32.1 | -51.7 | -48.5 | 1.3 | -10.9 | -5.2 | -7.1 | -6.8 | - | - | - | - |
P/S |
- | 25.7 | 18.2 | 12.4 | - | - | - | - | - | - | - | - | - |
EPS |
-0.1 | -0.1 | -0.2 | -0.4 | 17.2 | -0.6 | -0.9 | -1.6 | -1.2 | -0.9 | -0.5 | - | - |
EV (Enterprise Value) |
-12.4 M | -48.7 M | 103 M | 312 M | 228 M | 218 M | 142 M | 349 M | 169 M | -54.2 M | -6.4 M | -3.07 M | - |
EBITDA per Share |
-0.22 | -0.18 | -0.15 | -0.552 | -0.741 | -0.518 | -0.934 | -1.61 | -1.2 | - | - | - | - |
EV/EBITDA |
-4.4 | -19.1 | -5.8 | -11.6 | -4.3 | -6.6 | -4.4 | - | - | - | - | ||
PEG |
14.8 | 2.01 | 1.82 | 0.47 | 0.0 | -0.29 | -0.12 | 0.21 | 0.09 | - | - | - | - |
P/B |
0.8 | 0.4 | 1.2 | 1.6 | 1.2 | 5.6 | 2.8 | 6.4 | 2.5 | - | - | - | - |
P/CF |
-9.6 | -6.9 | 4.8 | -7.9 | -47.7 | -13.9 | -4.9 | -6.3 | -5.8 | - | - | - | - |
ROE % |
-2.12 | -1.33 | -2.40 | -3.22 | 88.49 | -51.06 | -55.10 | -89.33 | -36.37 | - | - | - | - |
ROA % |
-2.05 | -1.30 | -2.35 | -3.17 | 81.85 | -47.67 | -52.64 | -78.69 | -34.28 | - | - | - | - |
ROCE % |
-3.92 | -3.40 | -2.67 | -5.23 | -4.13 | -50.71 | -56.60 | -89.30 | -36.39 | - | - | - | - |
Current Ratio |
29.2 | 43.2 | 47.5 | 81.8 | 11.9 | 5.8 | 11.9 | 4.6 | 14.8 | - | - | - | - |
DSO |
- | - | 40.8 | 88.7 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | 1255.1 | 143.0 | 26.3 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | 40.8 | 88.7 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | -1255.1 | -102.2 | 62.3 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios XBiotech
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.24 | -0.29 | -0.13 | - | -0.42 | -0.38 | -0.18 | -0.21 | -0.11 | -0.17 | -0.09 | -0.06 | -0.09 | -0.24 | - | 16.67 | -0.15 | -0.16 | -0.16 | -0.17 | -0.14 | -0.16 | -0.11 | -0.2 | -0.18 | -0.26 | -0.32 | -0.5 | -0.38 | -0.42 | -0.32 | - | -0.33 | -0.22 | -0.29 | - | -0.29 | -0.16 | -0.19 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.22 | - | -0.14 | -0.35 | -0.23 | -0.24 | -0.06 | -0.31 | -0.1 | -0.17 | -0.1 | -0.19 | -0.04 | -0.32 | -0.11 | -0.13 | -0.14 | -0.17 | -0.09 | -0.12 | -0.1 | -0.21 | -0.16 | -0.26 | -0.3 | -0.5 | -0.37 | -0.41 | -0.31 | - | 0.35 | 0.22 | -0.29 | - | -0.27 | -0.15 | -0.19 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-13.91 | -15.77 | -16.50 | -11.75 | -14.15 | -10.17 | -7.09 | -5.79 | -3.91 | -3.45 | -3.94 | -3.22 | 88.16 | 88.07 | 89.26 | 88.49 | -17.13 | -28.51 | -42.01 | -51.06 | -48.35 | -46.46 | -47.37 | -55.10 | -70.82 | -81.64 | -89.52 | -89.33 | -71.98 | -61.27 | -44.75 | -24.84 | -36.63 | -38.01 | -38.08 | -26.04 | -26.04 | -14.25 | -7.63 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-13.55 | -15.39 | -16.04 | -11.41 | -13.76 | -9.88 | -6.95 | -5.68 | -3.85 | -3.40 | -3.89 | -3.17 | 81.39 | 81.35 | 82.57 | 81.85 | -15.97 | -26.61 | -39.21 | -47.67 | -45.40 | -43.86 | -45.04 | -52.64 | -65.59 | -74.35 | -80.17 | -78.69 | -64.05 | -55.25 | -41.10 | -23.40 | -34.60 | -35.98 | -36.10 | -24.72 | -24.72 | -13.52 | -7.24 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-15.24 | -14.02 | -12.96 | -10.29 | -12.96 | -11.71 | -10.03 | -8.08 | -6.82 | -6.80 | -5.63 | -5.24 | -5.59 | -5.06 | -3.99 | -4.13 | -17.13 | -28.67 | -41.46 | -50.71 | -48.44 | -47.04 | -49.56 | -56.61 | -71.97 | -82.11 | -89.05 | -89.33 | -51.00 | -19.41 | 9.87 | 8.76 | -3.06 | -25.38 | -38.23 | -26.07 | -26.07 | -14.25 | -7.63 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
33.1 | 38.7 | 46.4 | 43.2 | 41.6 | 25.0 | 51.6 | 47.5 | 52.1 | 65.6 | 92.6 | 69.3 | 69.3 | 69.3 | 69.3 | 13.3 | 13.3 | 13.3 | 13.3 | 15.1 | 15.1 | 15.1 | 15.1 | 22.4 | 22.4 | 22.4 | 22.4 | 8.4 | 8.4 | 8.4 | 8.4 | 17.3 | 17.3 | 17.3 | 17.3 | 19.8 | 19.8 | 19.8 | 19.8 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 41.5 | 14.9 | 45.6 | - | 0.7 | 17.3 | 54.6 | - | 35.6 | 24.2 | 14.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 812.8 | 832.5 | 726.6 | - | 102.9 | 91.5 | 73.8 | - | 24.1 | 17.2 | 21.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | 41.5 | 14.9 | 45.6 | - | 0.7 | 17.3 | 54.6 | - | 35.6 | 24.2 | 14.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | -771.2 | -817.6 | -681.0 | - | -102.2 | -74.3 | -19.3 | - | 11.5 | 7.0 | -7.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency